Trimeprazine Tartrate

   
Google
 
Web NewDrugInformation.com

Trimeprazine Tartrate


Drug - Trimeprazine Tartrate
The trade name of the product as shown on the labeling.

Dosage - SYRUP; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Trimeprazine Tartrate
Multiple ingredients are in alphabetical order.

Strength - EQ 2.5MG BASE/5ML
The potency of the active ingredient(s), Trimeprazine Tartrate. May repeat for multiple part products.

Applicant - ALPHARMA US PHARMS
The firm name holding legal responsibility for Trimeprazine Tartrate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 085015
The FDA assigned number to Trimeprazine Tartrate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Trimeprazine Tartrate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Feb 18, 1982
The date Trimeprazine Tartrate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Trimeprazine Tartrate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Trimeprazine Tartrate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Alpharma Us Pharmaceuticals Division
The full name of the firm holding legal responsibility for the new application of Trimeprazine Tartrate.

Trimeprazine Tartrate